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Streptomycetes are multicellular bacteria with complex developmental cycles. 
They are of biotechnological importance as they produce most bioactive 
compounds used in biomedicine, e.g. antibiotic, antitumoral and immunosupressor 
compounds. Streptomyces genomes encode a large number of Ser/Thr/Tyr kinases, 
making this genus an outstanding model for the study of bacterial protein 
phosphorylation events. We used mass spectrometry based quantitative proteomics 
and phosphoproteomics to characterize bacterial differentiation and activation of 
secondary metabolism of Streptomyces coelicolor. We identified and quantified 
3461 proteins corresponding to 44.3% of the S. coelicolor proteome across three 
developmental stages: vegetative hypha (MI); secondary metabolite producing 
hyphae (MII); and sporulating hyphae. A total of 1350 proteins exhibited more 
than 2-fold expression changes during the bacterial differentiation process. These 
proteins include 136 regulators (transcriptional regulators, transducers, 
Ser/Thr/Tyr kinases, signalling proteins), as well as 542 putative proteins with no 
clear homology to known proteins which are likely to play a role in differentiation 
and secondary metabolism. Phosphoproteomics revealed 85 unique protein 
phosphorylation sites, 58 of them differentially phosphorylated during 
differentiation. Computational analysis suggested that these regulated protein 
phosphorylation events are implicated in important cellular processes, including 
cell division, differentiation, regulation of secondary metabolism, transcription, 
protein synthesis, protein folding and stress responses. We discovered a novel 
regulated phosphorylation site in the key bacterial cell division protein FtsZ 
(pSer319) that modulates sporulation and regulates actinorhodin antibiotic 
production. We conclude that manipulation of distinct protein phosphorylation 
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events may improve secondary metabolite production in industrial streptomycetes, 
including the activation of cryptic pathways during the screening for new 
secondary metabolites from streptomycetes. 
 
INTRODUCTION 
Streptomyces is a genus of Gram-positive soil bacterium of great importance for 
biotechnology given their ability to produce a large array of bioactive compounds, 
including antibiotics, anticancer agents, immunosuppressants and industrial enzymes 
(1). Streptomyces has a complex morphogenesis which modulates secondary 
metabolism (2). After spore germination, a fully compartmentalized mycelium (MI) 
initiates development (3) until it undergoes an ordered programmed cell death (PCD)
 
(4) 
and differentiates to a second multinucleated mycelium (substrate mycelium, early MII) 
which activates secondary metabolism (2) before it starts to express the chaplin and 
rodlin genes encoding the proteins constituting the hydrophobic coats necessary for 
growth into the air (aerial mycelium; late MII) (5). At the end of the cycle, there is 
hyphal septation and sporulation (6). 
 Reversible protein phosphorylation at serine, threonine and tyrosine is a well-
known dynamic post-translational modification with stunning regulatory and signalling 
potential in eukaryotes (7). In contrast, the extent and biological function of Ser/Thr/Tyr 
protein phosphorylation in bacteria are poorly defined. Phosphorylation in bacteria is 
dramatically lower than in eukaryotes, making bacterial phosphoproteomics 
challenging. Several large-scale Ser/Thr/Tyr phosphoproteome studies in bacteria have 
been reported (8-24) (summarised in Table I), using, in most cases, large amounts of 
protein (milligrams) obtained during the vegetative growth to detect the relatively low 
number of phosphopeptides (Table I). This precludes application of isobaric mass 
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tagging quantitation strategies, since labelling such large amount of peptides is 
prohibitively expensive. This makes quantitative phosphoproteomics more difficult and 
to our knowledge, there are only six quantitative phosphoproteomic studies reported for 
bacteria. Some studies used stable isotope labelling by amino acids in cell culture 
(SILAC) (25-27), others used the scheduled reaction monitoring analyses (28, 29) and 
we performed a phosphopeptide profiling (label-free) quantitative proteomics study (16) 
(see Table I).  
Streptomyces coelicolor, the model Streptomyces strain (30), has 47 predicted 
eukaryotic-like protein kinases, twice the number predicted from genomes of other well 
characterized bacteria, including E. coli and B. subtilis, but 10-times less than human 
cells (31). S. coelicolor constitutes an outstanding model for the study of bacterial 
Ser/Thr/Tyr phosphorylation (16). The S. coelicolor chromosome was predicted to 
encode for 30 secondary metabolite biosynthetic pathways, 14 of them not yet 
experimentally observed (cryptic pathways) (32). None of these secondary metabolites 
has clinical applications, but S. coelicolor still is one of the best models to search for 
conserved pleiotropic secondary metabolism regulators in streptomycetes.  
Here we investigate dynamic regulation of the S. coelicolor proteome and 
phosphoproteome during differentiation in solid sporulating cultures at three 
developmental time points, 16-, 30- and 65-hours, corresponding to vegetative hyphae 
(MI), antibiotic producing hyphae (MII) and sporulating hyphae, respectively. This 
study reports the first isobaric-tag labelling quantitative phosphoproteomic study to 
identify Ser/Thr/Tyr phosphorylation implicated in secondary metabolism and 
differentiation in Streptomyces. Many of the proteins and phosphorylation sites 
differentially regulated during the vegetative (MI) and secondary metabolite producing 
mycelia (MII) are uncharacterised, but conserved in the Streptomyces genus. They are 
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potential modulators of secondary metabolism and differentiation. Genetic manipulation 
of the genes encoding these biomolecules might improve bioactive compound 
production in streptomycetes.  
 
EXPERIMENTAL PROCEDURES 
Bacterial Strains and Media – The S. coelicolor M145 strain was used in this 
study (30). Solid cultures were grown in Petri dishes (85 mm diameter) with 25 mL of 
solid GYM medium (glucose, yeast/malt extract) (33) that were covered with 
cellophane disks, inoculated with 100 μL of a spore suspension (1 x 107 viable 
spores/mL) and incubated at 30 ºC. FtsZ mutants were grown in solid SFM and MM 
(supplemented with mannitol) media (30). Liquid cultures were performed in sucrose-
free R5A (34) in 100 ml flasks, containing 20 ml media, at 200 rpm and 30ºC).  
Experimental design and statistical rationale – Three key developmental stages 
were analysed: vegetative hypha (MI16h), secondary metabolite producing hyphae 
(MII30h) and sporulating hyphae (MII65h) (Fig. 1). Quantitative proteomics and 
phosphoproteomics were performed by means of TMT-10-plex using 4:3:3 biological 
replicates from MI16h, MII30h and MII65h respectively (Fig. 1). In the case of the FtsZ 
mutants, samples were collected from sucrose-free R5A liquid cultures at 93-hours, the 
developmental time-point preceding the maximum phenotypical differences (see 
results), and TMT-11-plex was used (4:3:4 biological replicates from Ser-Ser, Glu-Glu 
and Ala-Ala FtsZ alleles respectively). As detailed below, abundance changes were 
statistically significant if they passed the differential expression test between the 
different developmental stages (q-value less than 0.01). 
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Sampling of S. coelicolor cells throughout the differentiation cycle - The 
mycelial lawns of S. coelicolor M145 grown on cellophane disks were scraped off at 
different time points (16- 30- and 65-h; MI, MII and sporulating MII) (Fig. 1) using a 
plain spatula. In the case of the FtsZ mutants, samples were collected from sucrose-free 
R5A liquid cultures at 93-hours by centrifugation at 20,000 g for 5 min. Samples were 
resuspended in 2% SDS, 50 mM pH 7 Tris-HCl, 150 mM NaCl, 10 mM MgCl2, 1 mM 
EDTA, 7 mM β-mercaptoethanol, EDTA-free Protease Inhibitor Cocktail Tablets from 
Roche and 1% phosphatase inhibitor mixtures 1 and 2 (Sigma) and lysed by boiling for 
10 minutes; sample viscosity was reduced by sonication (MSE soniprep 150, in four 
cycles of 10 s, on ice); cell debris were discarded after centrifugation at 20,000 g for 10 
min; the sample was cleaned by precipitation with acetone/ethanol 
(sample/EtOH/acetone 1:4:4 [v/v/v] overnight at -20ºC; washed with 
EtOH/acetone/H2O 2:2:1 [v/v/v]); resuspended in water; dialyzed against large volumes 
of water (1 h at 4ºC with four water changes); quantified as previously described (35); 
lyophilized in aliquots of 100 μg; and stored at -80ºC. 
 
Protein digestion - Lyophilized proteins were dissolved in 8 M urea in 100 mM 
TEAB buffer. Protein concentration was measured using bicinchoninic acid assay and 
adjusted to 2 mg of protein per mL. Samples were reduced with 5 mM DTT at room 
temperature for 1 h; S-alkylated with 15 mM iodoacetamide (15-30 min at RT in 
darkness); the alkylation reaction was stopped by adding DTT up to 15 mM; 300 µg of 
protein were digested using a combined trypsin/LysC digestion protocol (36); samples 
were desalted using Oasis HLB reverse-phase columns (Waters). 
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TMT labelling - Samples were labelled using TMT-10-plex or TMT-11-plex 
reagent (ThermoFisher). The 30- and 65 h samples were analysed in biological triplicate 
and the 16 h samples were analysed in quadruplicate. The samples from the strains 
harbouring the FtsZ Ser-Ser (wild-type) and the Ala-Ala alleles were analysed in 
quadruplicate, while the sample from the strain harbouring the FtsZ Glu-Glu allele in 
triplicate. Peptide concentration was quantified by amino acid analysis (37). For each 
condition, 60 µg of peptides was labelled with 0.5 mg of TMT-10-plex reagent 
following the manufacturer’s protocol. The samples were then combined (Fig. 1).  
 
Phosphoenrichment - Phosphopeptides were pre-enriched using calcium 
phosphate precipitation (CPP) as previously described (16, 38). One-hundred 
micrograms of TMT labelled peptides were precipitated using CPP and desalted using 
reverse phase chromatography (POROS R3 resin), before TiO2 enrichment (16) (Fig 1). 
The optimal proportion between TiO2 beads and peptides was tested using 100 µg of 
TMT labelled peptides (before CPP enrichment) and different amounts of TiO2 beads. 
The best phosphopeptide enrichment efficiency, producing an enriched sample 
containing 48 ± 1.8% phosphopeptide identifications, was obtained for 0.15 mg TiO2 
beads per 100 µg of TMT labelled peptide sample, vs. the 26 ± 2.3% and 20 ± 2.6% 
obtained with 0.6 and 1.2 mg TiO2 beads of TMT labelled peptides. 
 
LC-MS/MS analysis of the proteome and phosphoproteome temporal dynamics – 
Fifty micrograms of TMT-labelled peptides were fractionated by hydrophilic interaction 
liquid chromatography (HILIC) to generate twelve fractions. Each of the fractions was 
analysed by LC-MS/MS on EasyLC system (Thermo) coupled to Orbitrap-Fusion-
LUMOS. The LC aqueous mobile phase contained 0.1% (v/v) formic acid in water and 
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the organic mobile phase contained 0.1% (v/v) formic acid in 95% (v/v) acetonitrile. 
Before injection the trap and analytical columns were pre-equilibrated with 15 and 3.5 
µl buffer A, respectively. The samples were injected on a custom 3-cm trap column 
(100-µM internal diameter silica tubing packed with Reprosil 120 C18 5-µM particles) 
and desalted with 18 µl of buffer A. Separation was performed on a home-made 20-cm 
column (75-µM internal diameter silica tubing packed with Reprosil 120 C18 3-µM 
particles) with a pulled emitter at 250 nL min-1. For total proteome analysis, separation 
was performed with a 1-8% gradient over 3 min, 8 to 28% over 80 min, 28 to 40% over 
10 min and 40 to 100% over 5 min, the column was then kept at 100% buffer B for 8 
min. For phosphopeptide analysis, peptides were separated with 1 to 34% buffer B over 
60 min and 34 to 100% over 5 min and the column was then kept at 100% for 8 min.  
The eluted peptides were analysed on an Orbitrap Fusion mass spectrometer in 
data-dependent mode. The MS1 spectrum was acquired on an Orbitrap mass analyser at 
the 400-1600 mass range 120,000 resolution with an AGC target of 5e5 (60 ms 
maximum injection time). For MS2 scans, peptides were isolated with a quadrupole 
using a 1.2-Da isolation window and fragmented at 40% normalised collision energy. 
AGC was set at 5e4 (maximum injection time 120 ms) and dynamic exclusion was 20 s.  
Raw data are available via ProteomeXchange with identifier PXD005558. 
 
LC-MS/MS of the S. coelicolor FtsZ mutants - Fifty µg of TMT labelled peptides 
were fractionated by high pH LC into thirty fractions. Each of the fractions was 
analysed by LC-MS/MS using a Dionex Ultimate 3000 system (Thermo) interfaced to a 
Thermo Orbitrap Fusion Lumos electrospray ionization (ESI) tandem mass 
spectrometer. The LC mobile phases contained 0.1% (v/v) formic acid in water (A) and 
0.1% (v/v) formic acid in 100% (v/v) acetonitrile (B). The samples were injected on a 
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commercial trap column (300µM  5mm C18 PepMap 100) and desalted with 18 µl of 
solvent A. Separation was performed at 1.1µL/min on a home-made 50-cm column 
(150-µM internal diameter silica tubing packed with Inertsil C18 1.9-µM particles) at 
35C, equipped with 10µM ID emitter from PepSep (PSFSE10). The gradient was run 
from 2 to 10% B in 1 minute, from 10 to 12% in 2 minutes, from 12 to 28% in 44 
minutes, from 28 to 35% in 10 minutes, from 35 to 47% in 3 minutes. The column was 
then washed with 95% B for 3 minutes.  
The Lumos MS instrument was operated with the recommended settings for SPS 
analysis in data-dependent MS/MS mode. The MS1 spectrum was acquired using the 
Orbitrap mass analyzer at m/z 375-1500 at mass resolution 120.000, AGC target of 4e5 
(50 ms maximum injection time). For MS2 scans, peptides were isolated with the 
quadrupole using a 0.7 Da isolation window, fragmented at 35% normalized collision 
energy. Centroid spectra were collected in the ion trap in turbo mode. For MS3 scans, 
10 notches were selected in a 2 Da isolation window and fragmented at 65 NCE by 
HCD and reporter ions were detected at mass resolution 50.000 in the m/z 100-500 
range. 
Raw data are available via ProteomeXchange with identifier PXD005558. 
 
Data analysis - Data were analysed in Proteome Discoverer 2.1 software. A 
database search was performed with Mascot 2.3.2 using Streptomyces coelicolor 
UniProt database (retrieved on 06.03.15, 8038 entries). Methionine oxidation was set as 
variable modification, while Cys carbamidomethylation, TMT6plex (K) and TMT6plex 
(N-term) were specified as fixed modifications. A maximum of two trypsin missed 
cleavages were permitted. The precursor and fragment mass tolerances were 10 ppm 
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and 0.02 Da respectively. Contaminants from maxQuant website (retrieved May 2015) 
were excluded from the final analysis. Peptides were validated by Mascot Percolator 
with a 0.01 posterior error probability (PEP) threshold. For phosphopeptide analysis, the 
phosphorylation position was validated using the ptmRS algorithm. Peptide scores, 
precursor charge, peptide m/z, ptmRS scores, annotated mass labelled spectra for all 
phosphopeptides and other details are available via ProteomeXchange with identifier 
PXD005558. Peptide–spectrum matches, peptides per protein and protein coverage are 
indicated in supplemental Table S1. For phosphopeptides, we report the charge, m/z and 
mascot score for the highest confident PSM (that showing the highest Mascot score in 
our dataset) in supplemental Table S2. Peptide spectrum matches with total summed 
reporter intensities of less than 4e5 were not considered for quantitation due to the high 
level of noise in the quantitation data. The quantification results of peptide spectrum 
matches were converted to peptide-level quantitation, which in turn was converted into 
protein quantitation using an R script (39). Only proteins with two or more quantified 
peptides were considered. Proteins with similar temporal abundance profiles were 
clustered using a fuzzy c-means algorithm with a Euclidean distance matrix (40). 
Protein and phosphopeptide abundances of the reproductive stages (MII) were 
normalised against the vegetative stage (MI). The fold change of the MII stages (30- 
and 65- h) compared to the MI was estimated using the average TMT abundances from 
three or four biological replicates. Abundances were analysed for differential expression 
using the limma package in R (41). P- values for differential expression were adjusted 
for multiple comparisons using the R stats package. Phosphopeptide abundances were 
further normalized against the abundance of the non-phosphorylated proteins. Three 
thousand and eighty-three proteins exhibited significant expression changes (q-value 
less than 0.01) at least in one of the two MII stages compared to MI (supplemental 
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Table S1); seventy-eight phosphopeptides passed the abundance expression test (q-
value < 0.01) at least in one of the MII stages analysed compared to MI (supplemental 
Table S2).  
 
Analysis of protein functions - Proteins were classified into functional categories 
according to their annotated functions in the Gene Bank database, publications and by 
homology/functions according to the Gene Ontology (42), the Conserved Domain 
(https://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) and the KEGG Pathway 
(http://www.genome.jp/kegg-bin/show_organism?org=sco) databases. When a protein 
was involved in the synthesis of a specific secondary metabolite, it was classified in the 
secondary metabolism group, even if it matched additional categories. When a protein 
was involved in cell division regulation, it was included in cell division, instead of the 
category of regulatory proteins. 
 
FtsZ site-directed mutagenesis – Ser 319 (supplemental Table S2) and Ser 387 
(16) were replaced by Glu (to mimic phosphate group) and by Ala (to mimic 
nonphosphorylation). The synthesis of FtsZ mutated alleles was ordered to GeneCust. 
They included the FtsZ ORF and an upstream region (380 nucleotides) large enough to 
contain the three promoter regions described by Flärdh et al. (43). Genes were cloned in 
the integrative plasmid pNG3 (44) and introduced into S. coelicolor by conjugation 
(30). The native FtsZ ORF was mutated using the CRISPR-Cas9 system developed by 
Tong et al. (45). The 20-nt target sequence was selected inside the FtsZ gene and 
amplified using primers sgRNA-F 
(CATGCCATGGCGATGACTTTGATGACTGCGGTTTTAGAGCTAGAAATAGC) 
and sgRNA-R (ACGCCTACGTAAAAAAAGCACCGACTCGGTGCC). The product 
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of 110 bps was digested with NcoI/SnaBI and cloned in NcoI/SnaBI digested pCRISPR-
Cas9. The FtsZ surrounding regions were amplified by PCR with 2082LeftF 
(AGGCCTA GACCGACCACCGCCGAG) / 2082LeftR 
(CCTATCACTTCAGGAAGTCCGTGATGACTGCGAGGTAGTTCTG) and 
2082RightF (CAGAACTACCTCGCAGTCATCACGGACTTCCTGAAGTGATAGG) 
/ 2082RightR (AGGCCTAGTAACCGACCACGGAACGCA) primers. The two DNA 
fragments were combined by overlap extension PCR (46) using primers 2082LeftR and 
2082RightF. The PCR product was cloned and sequenced in pCR™-Blunt II-TOPO®. 
The insert was released with EcoRI, filled with the Klenow enzyme and cloned into 
pCRISPR-Cas9 (harbouring the 20-nt target sequence) digested with StuI. Mutations 
were confirmed by PCR using primers 2082LeftF and 2082RightR after plasmid 
clearance (45). 
 
Antibiotic quantification - Undecylprodigiosin and actinorhodin were quantified 
according to the spectrophotometric assays described by Tsao et al. (47) and Bystrykh 
et al. (48). Cells were ruptured in the culture medium by adding 0.1 N KOH. After 
vortexing and centrifugation, actinorhodin was quantified in the supernatant (ε640 
25,320). Undecylprodigiosin was measured after vacuum drying of the mycelium, 
followed by extraction with methanol and acidification with HCl (to 0.5 M) (ε530 
100,500). Analyses were performed in three biological replicas. 
 
Hypha and cell wall staining –Hypha and cell wall were stained using the 
LIVE/DEAD BacLight Bacterial Viability Kit (Invitrogen, L-13152) or Texas Red 
WGA (Invitrogen W21405) respectively as previously reported (49). Samples were 




1. MI and MII show distinctive proteomes and phosphoproteomes. 
A total of 3461 proteins (44.3% of S. coelicolor proteome) were identified and 
quantified (supplemental Table S1). Protein abundances were highly consistent across 
the biological replicates analysed (average correlation coefficient of 0.95; median 
coefficient of variation of 6.5%) (Fig. 2 and supplemental Table S1). Five clusters of 
proteins with similar temporal abundance profiles were identified (Fig. 3, supplemental 
Table S1): cluster 1 includes 345 proteins up-regulated at the MI stage; cluster 2 
includes 241 proteins up-regulated at the MI and MII30h stages; clusters 3-5 include 974 
proteins up-regulated at the MII stages. Most proteins demonstrating significant changes 
(q-value less than 0.01) in the MII30h and MII65h stages (compared to MI) showed 
similar trends i.e., they were up- or down-regulated in both (see heat maps in Figs. 4A 
and 5A) (supplemental Table S1). In order to focus on the most outstanding changes, 
we focused on the function of the 1350 proteins with significant expression changes and 
at least 2-fold change (log 2 ratio MII/MI lower than -1 or higher than 1). The 
abundances of key proteins are presented as histograms (Figs 4B and 5B), detailed 
below and outlined in Figure 6. 
Eighty-five unique phosphorylation sites (48% Ser, 52% Thr) from 92 
phosphopeptides and 48 phosphoproteins were identified (supplemental Table S2). All 
the phosphoproteins detected, were also identified and quantified in the proteomics set, 
which allowed us to normalise the change in phosphopeptide abundance against the 
change in protein, avoiding fluctuations due to variations in protein amount. To prevent 
artificial changes due to ratio suppression (underestimation of the relative change due to 
co-fragmentation of co-selected ions with similar m/z) (50) we focused on 
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phosphopeptides that passed the abundance expression test (q-value < 0.01) and showed 
at least two-fold increase or decrease in abundance (MII vs. MI) (58 phosphopeptides) 
(Figs. 7 and 8 and Table III). There is a clear and striking up-regulation of 
phosphorylation levels at MII, especially at 65 h (red bars in Fig. 7).  
 
2. Proteins responsible for biosynthesis of secondary metabolites are upregulated at 
MII stages. 
Proteins involved in secondary metabolite, such as actinorhodin, CPK, 
deoxysugar and coelichelin biosynthetic proteins, were up-regulated at both MII stages 
(clusters 3-5 in Fig. 3) (Figs. 4B and 6, Table II).  
We did not detect any Ser/Thr/Tyr phosphorylation in proteins involved in 
secondary metabolite biosynthesis. 
 
3. Proteins controlling aerial mycelium formation and sporulation showed different 
abundances at the MI and MII stages. 
Proteins involved in the regulation of the aerial mycelium formation and 
sporulation (Bld, Whi, Wbl, Sap proteins) showed different abundances between MI 
and MII (Figs. 4B and 6, Table II). Most of them were up-regulated at the MII stages as 
SapA (51), WhiE ORFs VI and VIII (52), BldB (53), WhiH (51), 
SCO4301/SCO6476/SCO6638 (potential BldA targets; they harbour Leu encoded by 
TTA) (54), BldN (55) and WblA (56). Others were down-regulated at the MII stages as 
BldD/BldC/BldKA (57), WblE (58), SCO3897/SCO6717 potential BldA targets and 
SCO3424, an uncharacterized BldB homologue.  
We did not detect any Ser/Thr/Tyr phosphorylation in proteins controlling aerial 
mycelium formation and sporulation. 
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4. Transcriptional regulators, transducers, Ser/Thr/Tyr kinases, and signalling proteins 
showed different abundances and phosphorylation at the MI and MII stages. 
One-hundred-thirty-six regulatory proteins (transcriptional regulators, 
transducers, Ser/Thr/Tyr kinases and signalling proteins) had different abundances in at 
least one of the MII stages compared to MI (supplemental Table S1). Well-characterised 
regulatory proteins were included here (Figs. 4B and 6, Table II). However, the 
regulatory role of most of these proteins has been inferred from amino acid sequence 
similarity to previously characterised regulators.  
Most of these regulatory proteins were up-regulated at the MII stages (most of 
them grouped into clusters 4 and 5) (Fig. 3): OhkA, a regulator of secondary 
metabolism and morphological differentiation (59); RarA-C “restoration of aerial 
mycelium formation’’ proteins (60); SarA, a protein involved in the regulation of 
sporulation and secondary metabolism (61); AtrA, an activator of the actinorhodin 
biosynthetic gene expressions (62); DevA, a GntR-Like transcriptional regulator 
controlling aerial mycelium development (63); NsdA, a BldD target regulating 
morphological differentiation and secondary metabolism (64); and ScbR, a γ-
butyrolactone binding protein regulating morphological differentiation and secondary 
metabolism (65). By contrast, some regulatory proteins were down-regulated at the MII 
stages: CspB, a repressor of secondary metabolism (66) and NusG, a transcription 
antiterminator repressing undecylprodigiosin production (67).  
As introduced above, the Streptomyces coelicolor genome encodes 47 
Ser/Thr/Tyr kinases. In this work we identified 40 of these kinases. Most of them were 
up-regulated at the MII65h stage (supplemental Table S2). The variation of eight 
Ser/Thr/Tyr kinases was over the 2-fold threshold (Fig. 4B): PkaE, an inhibitor of 
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actinorhodin production (68), PkaI, one of the proteins involved in spore wall synthesis 
(69) and six uncharacterised putative kinases (SCO1468, SCO2666, SCO3360, 
SCO3621, SCO3821, SCO4776). 
Seven regulatory proteins were differentially phosphorylated during 
development, especially at the MII65h stage (Table III) (Figs. 7A and 8): SCO0204, an 
orphan response regulator whose expression is affected by the sporulation-specific cell 
division activator SsgA (70); DevA, a GntR-like transcriptional regulator required for 
aerial mycelium development (63); DasR, a pleiotropic regulator of differentiation (71); 
SCO5357, rho transcription terminator involved in RNA degradation (KEGG pathway 
sco03018); SCO5544, part of the cvn1 conservon, a set of genes involved in regulating 
antibiotic production and aerial mycelium formation (72); SCO5704, a putative NusA 
transcription elongation factor; and SCO7463, a putative histidine kinase. 
 
5. Cell division proteins are differentially expressed and phosphorylated in the 
compartmentalised MI and the multinucleated MII hyphae. 
Forty-seven cell division proteins showed significant differences in their 
abundances between the MI and MII (supplemental table S1). Cell division proteins do 
not present large differences in abundance during Streptomyces differentiation (3). 
However, they are crucial in differentiation, controlling the compartmentalisation of the 
MI hyphae (3) and sporulation (73). Hence and only for cell division proteins, we 
discuss here all the well-characterised proteins showing significant variation, including 
those that did not pass the 2-fold threshold defined above (Figs. 4 and 6, Table II). 
Some cell division proteins that were reported to be involved in sporulation were up-
regulated at the MII stages (clusters 4 and 5 in Fig. 3): SffA (74), ParJ (75), CrgA (76), 
FemX (77), SCO4114 (78) and SmC (SCO5577) (79). Other well characterised cell 
17 
division proteins were down-regulated at the MII stages: DivIVA (80), FtsZ (81), MreC 
(69), ParA, ParB (82), the SCO4439 DD-CPase (83) and the nucleoid-associated HupS 
protein (84).  
Four proteins involved in cell division and cell wall synthesis were differentially 
phosphorylated during development (Table III) (Figs. 7A and 8). Three cell division 
proteins were phosphorylated at the MII65h stage: DivIVA, one of the proteins 
regulating apical growth in Streptomyces, which was demonstrated to be regulated by 
phosphorylation (80); SepF one of the proteins included in the Streptomyces division 
and cell wall (dcw) cluster (85) and FtsZ, the key tubulin-like bacterial division protein 
(81). SCO4439, a D-alanyl-D-alanine carboxypeptidase involved in sporulation (83), 
was phosphorylated at the MII30h and MII65h stages.  
 
6. Proteins involved in primary metabolism are differentially expressed and 
phosphorylated during development. 
Most proteins involved in protein synthesis (translation/protein folding) were up-
regulated at the MI (cluster 1 in Fig. 3) (Figs. 5 and 6, Table II). Proteins involved in 
energy production (krebs cycle, oxidative phosphorylation), lipid metabolism and 
catabolism were mostly up-regulated at the MII stages (Figs. 5 and 6, Table II). Other 
proteins involved in primary metabolic pathways were not clearly overrepresented in 
the MI or MII developmental stages (supplemental Table S1).  
Nine proteins involved in primary metabolism (translation, glycolytic enzymes, 
catabolism, nucleotide metabolism, folate biosynthesis) were differentially 
phosphorylated during development. Most of them were phosphorylated at the MII65h 
stage (Table III) (Figs. 7 and 8).  
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7. Stress proteins and chaperones are regulated by phosphorylation. 
Stress proteins and chaperones were not clearly overrepresented in the MI or 
MII developmental stages (supplemental Table S1). However, some of them were  
differentially phosphorylated during development, mostly at the MII65h (Figs. 7B and 8, 
Table III): PspA, a phage shock protein (86); chaperonin GroES; SCO5419, a putative 
thioredoxin; and SCO1836, a putative stress-like protein. 
 
8. Proteins and phosphoproteins of unknown function showed different abundances at 
the MI and MII stages. 
Five-hundred-forty-two uncharacterized proteins without any clear homology 
showed different abundances in at least one of the MII stages analysed compared to MI. 
As discussed below, these proteins constitute an outstanding database of potential 
regulators and effectors of differentiation (supplemental Table S1). For example, 
SCO5191 was up-regulated 11- and 8-fold at the MI16h stage compared to the MII30h 
and MII65h respectively, whereas SCO6650 was up-regulated 28-fold at the MII65h 
(Table II).  
Eight proteins with unknown functions were differentially phosphorylated 
during development. Interestingly, SCO2668 and SCO3859 were multiphosphorylated 
at eight and nine positions respectively (Fig. 7C) (supplemental Table S2) (Fig. 8) 
(Table III). SCO2668 has a “von willebrand factor type A” domain (vWA, conserved 
domain database accession cd00198) which is involved in a wide variety of important 
cellular functions (basal membrane formation, cell migration, cell differentiation, 
adhesion, homeostasis); SCO3859 has a “helix-turn-helix” domain (HTH, conserved 
domain database accession cl22854) which is present in several transcriptional 
regulators and other DNA binding proteins. Interestingly, phosphorylation in both 
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proteins do not look to be random, as it is localised into small regions (58 and 13 amino 
acids respectively), outside the conserved domains (Fig. 7C). 
 
9. Phosphorylation of FtsZ affects sporulation and secondary metabolism. 
As mentioned above, we identified a novel FtsZ phosphorylation at Ser 319 
(supplemental Table S2), which is significantly up-regulated at the MII30h and MII65h, 
1.25- and 4.1-fold respectively. In our previous label-free study, we identified another 
FtsZ phosphorylation at Ser 387 (16). In order to study the effect of these 
phosphorylations, we replaced the native FtsZ gene with two mutated alleles, one 
mimicking phosphorylation (replacing phosposerines by Glu) and another one 
mimicking non-phosphorylation (replacing phosphoserines by Ala), a well-established 
methodology to analyse the effect of Ser phosphorylation (see some examples in (87-
89).  
FtsZ is crucial for cell division and sporulation (90) and sporulation is affected 
in the FtsZ mutants. It is highly reduced in the strain harbouring the “Glu-Glu” allele 
and delayed in the strain harbouring the “Ala-Ala” allele (Fig. 9A). However, we did 
not observe differences in hypha septation between the FtsZ mutants and the wild-type 
strain during the vegetative stage (Fig. 9B). The Ala-Ala mutant shows a delayed 
growth at the early development compared to the Glu-Glu mutant and the wild-type 
strains (Fig. 9C). The most surprising phenotype, was the effect in secondary 
metabolism. Actinorhodin, purple pigmented polyketide antibiotic, was overproduced 
(2.9-fold) in the Ala-Ala mutant and repressed (0.53-fold the wild-type value) in the 
“Glu-Glu” mutant (Fig. 9C), in all the culture media (SFM, MM, GYM and R5A) and 
conditions (solid and liquid cultures) tested (Fig. 9C,D). The production of the tripyrrole 
antibiotic undecylprodigiosin, was slightly diminished (0.77-fold the wild-type value) in 
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the Ala-Ala mutant and highly repressed (0.24-fold the wild-type value) in the Glu-Glu 
mutant (Fig. 9C).  
Next we compared the proteomes of the FtsZ mutants and the wild-type strain 
(supplemental Table S3). Most of the proteins involved in secondary metabolism that 
showed significant variations, were up-regulated in the Ala-Ala mutant and down-
regulated in the Glu-Glu mutant (Fig. 10A). When we focus on the proteins that passed 
the 2-fold threshold (Fig. 10B), we observe that all the actinorhodin biosynthetic 
proteins are up-regulated in the Ala-Ala mutant and not in the Glu-Glu mutant, while 
the undecylprodigiosin biosynthetic proteins are down-regulated in both mutants 
compared to the wild-type strain (Ser-Ser allele). These results corroborate that the 
actinorhodin overproduction observed in the Ala-Ala mutant and the undecylprodigiosin 
repression detected in the Ala-Ala and the Glu-Glu mutants (Fig. 9C), are regulated at 
the protein level. 
 
DISCUSSION 
Here we quantified the variation of 3461 proteins during the MI and MII stages 
in Streptomyces coelicolor. This corresponds to 44.3% of S. coelicolor theoretical 
proteome and 45% of the transcriptome identified by us in a previous work at the same 
developmental stages (91). Our results exceed any previous quantitative studies of the S. 
coelicolor proteome (92-96), quintuplicating the number of proteins quantified in our 
previous MI and MII quantitative proteomic study (16). We also quantified the variation 
of 92 phosphopeptides from 48 phosphoproteins during development, using the 
proteome abundances to normalise the phosphoproteome abundances and reporting the 
first quantitative dataset of Ser/Thr/Tyr phosphorylation variations during Streptomyces 
differentiation. We used MS2 TMT to profile proteome and phosphoproteome temporal 
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changes, which is a method known to suffer from ratio suppression (97). However, we 
and others have studied the issue of ratio compression in TMT based quantitative 
proteomics and have concluded that the effect on the overall outcome of proteomics 
studies can be neglected, unless high precision is needed (98-100). In order to reduce 
the interference of ratio suppression, we focused on the most reliable quantitative data, 
i.e. proteins and phosphopeptides that changed in abundance by at least two-fold. 
Despite this very stringent criterion, we found that 1350 proteins (supplemental Table 
S1) and 58 phosphopeptides (supplemental Table S2) were changing, indicating 
significant reorganisation of the Streptomyces coelicolor proteome and 
phosphoproteome throughout its life cycle. As described above, most of the 40 
Ser/Thr/Tyr kinases identified, as well as Ser/Thr/Tyr phosphorylations were 
overrepresented at the sporulating stage (MII65h), indicating a role of Ser/Thr/Tyr 
phosphorylation in the regulation of differentiation and sporulation.  
The clearest physiological difference between the MI and MII is the activation 
of secondary metabolism at the MII (91, 95) and most proteins involved in secondary 
metabolism were highly up-regulated at the MII stages (CPK, ACT, deoxysugar 
synthases, coelichelin). By contrast, a majority of proteins involved in primary 
metabolism, particularly those involved in protein synthesis, translation and protein 
folding were highly up-regulated in the MI stage, which is not strange, considering that 
the MI corresponds to the exponential vegetative growth stage, while growth is arrested 
at the MII stage (101). Other primary metabolism proteins involved in energy 
production (krebs cycle, oxidative phosphorylation), lipid metabolism, amino acid 
metabolism and pentose phosphate pathway, were mostly up-regulated in MII stages, 
perhaps contributing the energy and precursors necessary for secondary metabolism. 
Secondary metabolism is associated to MII (4), but the expression of different 
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secondary metabolites need specific activators (elicitors) or repressors and not all 
secondary metabolites are produced simultaneously in the MII (5, 102). For instance, 
AtrA (SCO4118), an activator of actinorhodin biosynthetic genes (62) is slightly up-
regulated at the MII65h (2.1-fold), activating actinorhodin production, while PkaE, a 
repressor of actinorhodin production was also up-regulated at the MII65h (2.8-fold), 
indicating that actinorhodin production is blocked in sporulating hyphae as reported 
before (91, 95). SCO6286, a CPK repressor (103), was up-regulated at the MII65h, 
blocking CPK production during the aerial mycelium stage. SCO3225 and SCO3226, a 
two-component system repressing CDA biosynthesis showed similar abundances at the 
MI and MII stages (supplemental Table S1), repressing CDA production under the 
culture conditions used in this work.  
The clearest morphological difference between MII30h (substrate mycelium) and 
MII65h (aerial sporulating mycelium), is the presence of hydrophobic coats in the aerial 
sporulating hyphae and proteins involved in the regulation of hydrophobic cover 
formation and sporulation (Bld, Whi, SapA, RarA-C) were up-regulated in the MII65h.  
None of the enzymes synthesising secondary metabolites, or the proteins 
forming the hydrophobic coats were detected as phosphorylated, indicating that 
modulation of these processes by Ser/Thr/Tyr phosphorylation is not at the final 
effectors. By contrast, some proteins and enzymes involved in central metabolic 
pathways (translation, glycolytic enzymes, catabolism, nucleotide metabolism, folate 
biosynthesis) were differentially phosphorylated in the MI and MII, suggesting that 
their activities are modulated by phosphorylation. 
 There are two developmental stages in which Streptomyces hyphae are 
compartmentalised, the MI and the sporulating MII, while the early stages of MII 
(substrate and aerial hyphae) consist in multinucleated hyphae with sporadic septa. 
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Streptomyces cell division studies focused on sporulation, while MI cell division 
remains poorly known. Recently, our group, was able to identify the existence of a new 
kind of cell division based on cross-membranes without detectable peptidoglycan in the 
MI hyphae (3, 104), whose regulation remains basically uncharacterised. Here, we 
detected several cell division proteins more abundant at the MI stage than at the 
sporulating MII stage. This result suggest a putative role of these proteins in the MI 
cross-membrane based cell division, as it happens with FtsZ, the key effector of 
bacterial cell division (3). These proteins constitute a good starting point to study the 
mechanisms controlling cross-membrane cell division in Streptomyces.  
Cell division proteins such as DivIVA and FtsZ were more phosphorylated 
during the MII65h stage, suggesting a role of phosphorylation in the regulation of cell-
division accompanying sporulation. FtsZ phosphorylation has a direct effect in 
sporulation, that is highly reduced in the mutant mimicking double phosphorylation 
(“Glu-Glu” allele). This might indicate that phosphorylation affects FtsZ 
polymerization, reducing sporulation, as it happens in Mycobacterium tuberculosis 
(105). Interestingly, we detected a dramatic effect of FtsZ phosphorylation in 
actinorhodin production. FtsZ is highly conserved in the Streptomyces genus and the 
“Ala-Ala” allele, might be used in industrial streptomycetes to enhance the production 
of other antibiotics. Further work will be necessary to fully understand the biological 
role of FtsZ phosphorylation and its potential industrial application.  
One-hundred-thirty-six regulatory proteins (transcriptional regulators, 
transducers, Ser/Thr/Tyr kinases and signalling proteins), most of them uncharacterised 
putative regulators identified by amino acid sequence homology, and 542 putative 
proteins (without any clear homology) showed differential abundances during MI and 
MII. Key regulatory proteins were differentially phosphorylated during S. coelicolor 
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development, such as DasR or DevA, two pleiotropic regulators controlling secondary 
metabolism and aerial mycelium formation. These results suggest a putative role of 
phosphorylation in the regulation of secondary metabolism, aerial mycelium formation 
and sporulation to be studied and characterised in the future. Eight proteins without 
known function were also differentially phosphorylated during development. For 
instance, SCO2668 is highly multiphosphorylated at the sporulating mycelium (MII65h), 
and harbours a pleiotropic eukaryotic vWA domain which is involved in a wide variety 
of important cellular functions in eukaryotic cells (basal membrane formation, cell 
migration, cell differentiation, adhesion, homeostasis). This suggests a complex 
regulatory role of SCO2668 in sporulation, resembling eukaryotic regulatory 
pathways. S. coelicolor is the best characterised streptomycete, despite that it does not 
produce commercial secondary metabolites. However, many of the phosphorylated 
proteins, as well as regulatory proteins and proteins with unknown function 
differentially expressed during the vegetative (MI) and secondary metabolite producing 
mycelia (MII), are conserved in the Streptomyces genus. These proteins are potential 
modulators of secondary metabolism and differentiation to be studied and characterised 
in the future, as it happens with FtsZ. This knowledge can contribute to the optimisation 
of secondary metabolite production in industrial streptomycetes, including the 
activation of cryptic secondary metabolite pathways (pathways that are not activated in 
laboratory cultures) during the screening for new secondary metabolites from 
streptomycetes (106). 
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Table I: Comparison of the S. coelicolor phosphoproteome with other published 
prokaryotic and human phosphoproteomes. Quantitative phosphoproteomic studies are 













S. coelicolor 0.1 48 92 85 This work 
S. coelicolor 0.3 127 260 289 (16)*  
S. coelicolor 50 40 44 46 (18)  
S. erythraea 10 88 109 n.r. (28)*  
B. subtilis 10 78 103 78 (15)  
B. subtilis 12 139 177 144 (31)*  
C. acetobutylicum 2 61 82 107 (9) 
L. lactis 20 63 102 79 (22)  
M. tuberculosis n.r. 301 380 500 (19)  
S. pneumoniae 1 84 102 163 (23)  
L. monocytogenes 10 112 155 143 (17)  
L. monocytogenes 8 191 256 242 (27)*  
S. aureus 50 108 n.r. 76 (10)  
Gram - 
E. coli 20 79 105 81 (14)  
K. pneumoniae 30 81 117 93 (13)  
 P. aeruginosa 1.2 39 57 61 (20)  
P. putida 1.2 59 56 55 (20)  
H. pylori n.r. 67 82 126 (11)  
R. palustris (Ch) 2 54 100 63 (12) 
R. palustris (Ph) 2 42 74 59 (12)  
T. thermophilus 100 48 52 46 (24)  
E. coli 9.8 133 n.r. 108 (25)*  
E. coli 10 n.r 34 n.r. (29)*  
A. baumanii 
Abh12O-A2 
9 70 n.r. 80 (21)  
A. baumanii 
ATCC 17879 
9 41 n.r. 48 (21)  
      
Archaea H. salinarum 20 26 42 31 (8)  
Eukarya H. sapiens 6 7832 >50000 38229 (108) 
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Table II: Averaged TMT protein abundances (from at least three biological replicates) 
of the substrate mycelium (MII30h) and sporulating aerial mycelium (MII65h) compared 
to the MI stage (16 h). The MII/MI ratio is shown in logarithm (log 2) and linear forms. 
Cl, clusters of proteins with similar abundance profiles. N.S. Not significant (q-value 
higher than 0.01). (-) The significant value that did not pass the 2-fold threshold. The 
proteins discussed in the text are indicated. Only changes of more than 2-fold up or 
down-regulated are shown, except for cell division proteins. 
 













SCO6286 4 CPK repressor 1 1.8 1.9 3.5 
SCO6276 3 
CPK biosynthesis 
2 n.s. 4 n.s. 
SCO6277 3 1.9 - 3.8 - 
SCO6278 3 1.4 n.s. 2.7 n.s. 
SCO6279 n.s. 2.6 1.6 6 3 
SCO6282 3 2.7 - 6.5 - 




1 -1.5 2 0.3 
SCO0492 3 1.1 n.s. 2.1 n.s. 
SCO0498 3 1.6 - 3 - 
SCO0499 3 1.2 n.s. 2.3 n.s. 
SCO5072 5 
ACT biosynthesis 
n.s. 3.6 n.s. 12.1 
SCO5073 5 n.s. 2.7 n.s. 6.5 
SCO5074 5 n.s. 4.6 n.s. 24.2 
SCO5075 5 n.s. 2.2 n.s. 4.6 
SCO5077 n.s. - 2.1 - 4.3 
SCO5078 5 n.s. 3 n.s. 8 
SCO5079 5 - 3.4 - 10.5 
SCO5080 5 n.s. 3 n.s. 8 
SCO5083 5 n.s. 1.9 n.s. 3.7 
SCO5084 5 n.s. 3 n.s. 8 
SCO5086 n.s. n.s. 1.6 n.s. 3 
SCO5087 5 n.s. 1.9 n.s. 3.7 
SCO5088 5 n.s. 1.6 n.s. 3 
SCO5089 n.s. - 2.1 - 4.3 
SCO5090 5 n.s. 2.4 n.s. 5.3 




n.s. 2.5 n.s. 5.8 
SCO0382 n.s. - 2.5 - 5.8 
SCO0383 5 - 2.7 - 6.3 
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SCO0384 5 n.s. 2.4 n.s. 5.4 
SCO0385 5 n.s. 2.1 n.s. 4.3 
SCO0386 5 - 2.6 - 5.9 
SCO0387 n.s. - 2.3 - 5 
SCO0388 5 - 2.8 - 7 
SCO0389 5 - 2.8 - 7 
SCO0391 5 n.s. 2.1 n.s. 4.2 
SCO0392 4 - 1.9 - 3.7 
SCO0393 n.s. 1 3.1 2 8.2 
SCO0394 5 - 3.3 - 9.6 
SCO0395 n.s. 1 3.1 2 8.7 
SCO0396 5 - 3.3 - 9.9 
SCO0398 5 - 2.7 - 6.4 
SCO0399 4 1.2 2.8 2.3 7 
SCO0400 n.s. - 2.6 - 6.7 
SCO0401 n.s. - 2 - 4 
Bald/whi 
Sap 
SCO0409 5 SapA - 1.7 - 3.2 
SCO1489 n.s. BldD - -1.5 - 0.3 
SCO3323 n.s. BldN 1.5 1.9 2.8 3.7 
SCO3424 1 BldB homologue -1.8 -1.8 0.3 0.3 
SCO3579 n.s. WblA 1.1 1.6 2.1 3 
SCO4091 n.s. BldC - -1.8 - 0.3 
SCO5112 n.s. BldKA -1.1 n.s. 0.5 n.s. 
SCO5240 n.s. WblE - -2.6 - 0.2 
SCO5315 5 WhiE ORFVI n.s. 1.6 n.s. 3 
SCO5321 5 WhiE ORFVIII n.s. 1.8 n.s. 3.5 
SCO5723 n.s. BldB - 1.5 - 2.8 





-1.4 -2.7 0.4 0.2 
SCO4301 4 - 1.5 - 2.8 
SCO6476 n.s. - 1.4 - 2.6 
SCO6638 n.s. 1 1.3 2 2.5 





SCO1416 5 SffA n.s. 0.8 n.s. 1.7 
SCO1662 n.s. ParJ 0.33 0.55 1.3 1.5 
SCO2077 n.s. DivIVA n.s. -0.9 n.s. 0.5 
SCO2082 2 FtsZ -0.2 -0.8 0.9 0.57 
SCO2610 2 MreC n.s. -0.7 n.s. 0.6 
SCO3854 5 CrgA n.s. 1.4 n.s. 2.6 
SCO3886 n.s. ParA -0.3 -0.6 0.8 0.7 
SCO3887 2 ParB n.s. -0.3 n.s. 0.8 




0.4 0.2 1.3 1.1 
SCO4439 n.s. DD-CPase -0.4 -0.7 0.8 0.6 
SCO5556 1 HupS -2 -1.7 0.25 0.3 
SCO5577 n.s. SmC n.s. 0.6 n.s. 1.5 




SCO1596 n.s. OhkA - 1.5 - 2.8 
SCO1628 4 RarC 1.6 3.1 3 8.6 
SCO1629 n.s. RarB - 2.6 - 6.1 





n.s. 1.3 n.s. 2.5 




















0.4 1.5 1.3 2.9 
SCO4778 n.s. PkaI 0.9 1.5 1.9 2.8 
SCO4069 n.s. SarA - 1.5 - 2.8 
SCO4118 4 AtrA - 1.1 - 2.1 
SCO4190 5 DevA n.s. 1.3 n.s. 2.5 
SCO4325 n.s. CspB - -2.2 - 0.2 
SCO4647 n.s. NusG - -1.9 - 0.3 
SCO5582 4 NsdA - 1.1 - 2.1 








































2.1 n.s. 4.2 n.s. 





 For cell division proteins, variations inside the ±1 interval showing significant 












































- 2.2 - 4.7 
SCO5443 5 Alpha-amylase n.s. 2.2 n.s. 4.7 
SCO6411 5 Hydrolase - 2 - 4 
SCO6414 4 Hydrolase 1.2 2.3 2.3 4.9 
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Table III: Averaged TMT phosphopeptide abundances (from at least three biological 
replicates) of the substrate mycelium (MII30h) and sporulating aerial mycelium (MII65h) 
compared to the MI stage (16 h), of the phosphopeptides and phosphoproteins discussed 
in the manuscript. The MII/MI ratio is shown in the logarithm (log 2) and linear forms. 
N.S. Not significant (q-value higher than 0.01). (-) significant abundance values that did 
not pass the 2-fold threshold. Phosphorylation sites are highlighted in bold. 
















SCO0204 AHpSEQGDNTGSPVR n.s. 3.1 n.s. 8.5 
DevA 
(SCO4190) 





STDVSSAENEGGApTVR n.s. 2.1 
n.s. 
4.3 
SCO5357 VNASAEQAAPADDAPpSER n.s. 1.6 n.s. 3 
SCO5544 GHDEPDpSSRTDR n.s. 3.2 n.s. 9.2 
SCO5544 GHDEPDSpSRTDRTPR n.s. 1.9 n.s. 3.7 
SCO5544 GHDEPDpSpSRTDRTPR n.s. 3.6 n.s. 12 
SCO5704 IDIRPDTEQPSDASPEQSpSGGRGE n.s. 4.8 n.s. 27.8 





QLETQADDpSLAPPR n.s 1.6 n.s 3.1 
SepF 
(SCO2079) 
IAEGGFFNQpS n.s. 1.1 n.s. 2.1 
SCO2082 
(FtsZ) 





















































n.s. 2.4 n.s. 5.4 
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SCO4703 AVDpTEGSEA n.s. 3.3 n.s. 9.6 




 ApTRpSpTEEVEEQAQDAQASEDLK n.s. 1.1 n.s. 2.2 
SCO1646 pSTEEVEEQAQDAQASEDLK n.s. 1.2 n.s. 2.3 
SCO1646 ApTRSTEEVEEQAQDAQASEDLK n.s. 1.6 n.s. 3 
SCO1646
1
 ApTRpSTEEVEEQAQDAQASEDLK n.s. 3.1 n.s. 8.5 
SCO5864 KTDDDVDSDpSLEELK n.s. 3.3 n.s. 9.9 
SCO5864 TDDDVDpSDSLEELK n.s. 3 n.s. 8 










SCO3542 ELPQIDPDQAPPpSR n.s. 2 n.s. 4 









Glycoslisis SCO7443 TSGLADGVVVTPpSHNPPADGGFK n.s. 1.4 n.s. 2.7 
Unknown 
SCO2668 AGDIDGApTAK n.s. 1.1 n.s. 2.1 
SCO2668 VEEADEMTLETRpSpTKpTVR n.s. 1.9 n.s. 3.8 
SCO2668 AVQLAGVSGNADpTAK 1.62 1.3 3.1 2.5 
SCO3859 SQGGSVLSNTTpTTTpSpSSGAPTVK n.s. 3 n.s. 8.2 
SCO3859 SQGGSVLSNTTTpTTpSpSSGAPTVK n.s. 3.4 n.s. 10.4 
SCO3859 SQGGSVLSNTTTpTpTpSpSSGAPTVK n.s. 3.3 n.s. 9.6 
SCO3859 SQGGSVLSNTTTTpTpSpSSGAPTVK n.s. 3.4 n.s. 10.4 
SCO3859 SQGGSVLSNpTTTTTSpSSGAPTVK n.s. 3.2 n.s. 9.3 
SCO3859 SQGGpSVLSNTTTTTSpSSGAPTVK n.s. 3.5 n.s. 11.2 
SCO3859 SQGGSVLSNTTTTTpSpSSGAPTVK  n.s. 3.9 n.s. 14.8 
SCO3859 SQGGSVLSNTTTTpTSpSSGAPTVK n.s. 5.3 n.s. 40.2 
SCO3859 SQGGSVLSNTpTTTTSpSSGAPTVK n.s. 5.9 n.s. 61.1 
SCO3859 SQGGSVLSNTTTTpTSpSpSGAPTVK n.s. 3.4 n.s. 10.9 
SCO3859 SQGGSVLSNTTpTpTTpSpSSGAPTVK n.s. 3 n.s. 8 
SCO3859 SQGGSVLSNpTpTpTTTSpSSGAPTVK n.s. 4.1 n.s. 17 
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 Only one phosphorylation site, at one of the positions marked, exists. See 








FIG. 1. Sample preparation. S. coelicolor hyphae stained with SYTO 9 and propidium 
iodide observed under the confocal microscope at the compartmentalised MI (16 h), 
multinucleated substrate mycelium (MII30h) and sporulating aerial mycelium (MII65h) 
stages are shown (upper panels). TMT labelling and the phosphopeptide enrichment 
workflows are outlined. 
 
FIG. 2. TMT abundance values distribution and correlation between biological 
replicates. The distribution of the TMT abundances of two biological replicates of each 
developmental stage analysed (MI16h, MII30h and MII65h) (panels in the diagonal), the 
correlation and coefficients of regressions of TMT abundances between biological 
replicates of the same developmental stage (marked in black) and the correlation and 
coefficients of regressions of TMT abundances between different developmental stages 
(marked in red), are shown. Notice the good correlation between replicates of the same 
developmental stage and the poor correlation between replicates of different 
developmental stages.  
 
FIG. 3. Clusters of the proteins with similar temporal abundance profiles. Cluster 1, 
proteins up-regulated at the MI16h stage; Cluster 2, proteins up-regulated at MI16h and 
MII30h; Clusters 3-5, proteins up-regulated at the MII stages. 
 
FIG. 4. Abundances (logarithm of TMT MII/MI) of proteins related with 
secondary metabolism, aerial mycelium formation, sporulation, cell division and 
regulation of cellular processes (transcriptional regulators, transducers 
Ser/Thr/Tyr kinases and signalling proteins). Proteins involved in the synthesis of 
34 
specific secondary metabolites, were classified in the secondary metabolism group, even 
if they fitted additional categories; proteins involved in cell division regulation, were 
included in cell division (see Methods). A, Heat maps outlining the TMT abundances of 
proteins with significant variations in both MII stages with respect to MI. Asterisks 
indicate the few proteins showing opposite differences in both MII (i.e. up-regulated at 
MII30h and down-regulated at MII65h or vice versa). B, TMT abundances of the key 
proteins described in the text. Abundances have significant differences (q-value < 0.01) 
and passed the 2-fold threshold in at least one of the MII stages, except for cell division 
proteins, in which proteins below the 2-fold threshold, but showing significant 
differences, are also shown. The SCO numbers are indicated. Dashed lines indicate the 
2-fold threshold. “K” indicates Ser/Thr/Tyr kinases. 
 
FIG. 5. Abundances (logarithm of TMT MII/MI) of proteins related with central 
(primary) metabolism (aerobic energy production, catabolism, translation/protein 
folding). A, heat maps. B, TMT abundances of the key proteins described in the text. 
Statistics and labelling as in Fig. 4. 
 
FIG. 6. Integrated S. coelicolor proteome variations during development (MI16h, 
MII30h and MII65h). The key proteins discussed in the text are shown at the 
developmental stage in which they display significant up-regulation (q-value < 0.01). 
 
FIG. 7. S. coelicolor phosphoproteome. A-B, Thirty-five peptides differentially 
phosphorylated during development (q-value < 0.01) that passed the 2-fold threshold at 
least in one of the MII stages grouped into functional categories. The SCO numbers are 
indicated. Dashed lines indicate the 2-fold threshold. The 23 peptides differentially 
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phosphorylated, belonging to proteins with unknown function, are not shown. C, 
Outline indicating the phosphorylation sites and conserved protein domains of two 
multiphosphorylated proteins with unknown function. 
 
FIG. 8. S. coelicolor integrated phosphoproteome variations during development 
(MI16h, MII30h and MII65h). The key proteins discussed in the text are shown at the 
developmental stage in which they display significant phosphorylation site up-
regulation (q-value < 0.01). 
 
FIG. 9. Phenotypes of the S. coelicolor harbouring the FtsZ wild-type gene (Ser-
Ser), the FtsZ mutant mimicking duble phosphorylation (“Glu-Glu”) and the FtsZ 
mutant mimicking no phosphorylation (“Ala-Ala”). A, macroscopic view of 
sporulated cultures 96-hours in SFM medium); the grey colour corresponds to spores. B, 
peptidoglycan staining (WGA staining) of vegetative hyphae (15-hours in GYM 
cultures). Arrows indicate septa. C, sucrose-free R5A liquid cultures; upper panel, 
growth curve (protein/ml); middle panel actinorhodin production; lower panel 
undecylprodigiosin production. D, macroscopic view of solid cultures; SFM and GYM 
at 72 h, MM at 96 h. Purple colour actinorhodin, red colour undecylprodigiosin (not 
visible at the time points shown). 
 
FIG. 10. Abundances of proteins implicated in secondary metabolism in the FtsZ 
Glu-Glu and Ala-Ala mutants compared to the wild-type strain (Ser-Ser). A, heat 
maps. B, TMT abundances of the key proteins described in the text. Statistics and 
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